BMJ  2005;330:5-6 (1 January), doi:10.1136/bmj.330.7481.5

Editorial

Direct to consumer advertising

Is at the crossroads of competing pressures from industry and health needs

The first 150 words of the full text of this article appear below.

The challenge for governments evaluating direct advertising of prescription only drugs to the consumer is how to achieve maximum benefits for health and wealth while minimising harm. New Zealand's health minister, Annette King, has taken the advice of New Zealand's health professional and consumer groups and has decided that the potential benefits of "direct to consumer advertising" do not justify the harms and so plans to ban it from 2005.^w1 That will leave the United States as the only industrialised country allowing full direct to consumer advertising of prescription medicines. An Australian review of drug legislation in 2001 concluded that prohibiting such advertising produces a net benefit for the community as a whole.¹ In 2002, the European Parliament rejected a proposal to allow advertising for drugs used to treat asthma, AIDS, and diabetes directly to the consumer. A 2004 Canadian parliamentary inquiry recommended against direct to consumer advertising because . . . [Full text of this article]

Healthy Skepticism Inc., 34 Methodist St., Willunga, SA 5172, Australia (peter@healthyskepticism.org)

University of British Columbia, #429-2194 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3

Department of Public Health and General Practice, Christchurch School of Medicine, University of Otago, PO Box 4345, Christchurch, New Zealand

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Over the counter medicines: proceed with caution

Robin E Ferner and Keith Beard
BMJ 2008 336: 694-696. [Extract] [Full Text] [PDF]

Tooth and nail

Fiona Godlee
BMJ 2007 335: 0. [Extract] [Full Text]

Direct to consumer marketing: Switch to over the counter can become indirect advertising directly to consumers

Martin Duerden and Tom Walley
BMJ 2005 330: 906. [Extract] [Full Text]

Direct to consumer marketing: Advertising directly to consumers may affect patients' safety

Mark Hochhauser
BMJ 2005 330: 906. [Extract] [Full Text]

This article has been cited by other articles:

• Rutter, P., Gilbody, S. (2008). The European pharmaceutical industry: coming to a screen near you?. JRSM 101: 485-488 [Full text]  
• Freeman, B, Chapman, S (2008). Gone viral? Heard the buzz? A guide for public health practitioners and researchers on how Web 2.0 can subvert advertising restrictions and spread health information. J. Epidemiol. Community Health 62: 778-782 [Abstract] [Full text]  
• Ferner, R. E, Beard, K. (2008). Over the counter medicines: proceed with caution. BMJ 336: 694-696 [Full text]  
• Frosch, D. L., Krueger, P. M., Hornik, R. C., Cronholm, P. F., Barg, F. K. (2007). Creating Demand for Prescription Drugs: A Content Analysis of Television Direct-to-Consumer Advertising. Ann Fam Med 5: 6-13 [Abstract] [Full text]  
• Hollon, M. F. (2005). Direct-to-Consumer Advertising: A Haphazard Approach to Health Promotion. JAMA 293: 2030-2033 [Full text]  
• Duerden, M., Walley, T. (2005). Direct to consumer marketing: Switch to over the counter can become indirect advertising directly to consumers. BMJ 330: 906-906 [Full text]  
• Hochhauser, M. (2005). Direct to consumer marketing: Advertising directly to consumers may affect patients' safety. BMJ 330: 906-906 [Full text]  

Rapid Responses:

Read all Rapid Responses

New Year's Resolution

Mark McConnell, MD
bmj.com, 4 Jan 2005 [Full text]

Does direct to consumer advertising affect patient safety?

Mark Hochhauser
bmj.com, 4 Jan 2005 [Full text]

When OTC marketing becomes direct to consumer advertising

Martin G Duerden, et al.
bmj.com, 11 Jan 2005 [Full text]

Correction: When OTC marketing becomes direct to consumer advertising

Martin G Duerden
bmj.com, 12 Jan 2005 [Full text]